1. Asparaginase pharmacology: challenges still to be faced
   Claudia Lanvers-Kaminsky, 2017, Cancer Chemother Pharmacol CrossRef
2. Icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2.
   Jingwei Li et al, 2015, Oncol Rep CrossRef
3. Polymer therapeutics: Top 10 selling pharmaceuticals — What next?
   Ruth Duncan, 2014, Journal of Controlled Release CrossRef
4. Chitosan-modified lipid nanovesicles for efficient systemic delivery of l -asparaginase
   Shengli Wan et al, 2016, Colloids and Surfaces B: Biointerfaces CrossRef
5. The peculiarities of cancer cell metabolism: A route to metastasization and a target for therapy
   Tiago MA. Carvalho et al, 2019, European Journal of Medicinal Chemistry CrossRef
6. The role of autophagy in asparaginase-induced immune suppression of macrophages
   Ping Song et al, 2017, Cell Death Dis CrossRef
7. Investigational cancer drugs targeting cell metabolism in clinical development
   Douglas W Sborov et al, 2015, Expert Opinion on Investigational Drugs CrossRef
8. L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors
   Kwangsoo Kim et al, 2015, Molecular Therapy - Oncolytics CrossRef
9. Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma
   Jean-Baptiste Bachet et al, 2015, Pancreas CrossRef
10. null
    Dalit Landesman-Milo et al, 2016 CrossRef
11. SLC 1A3 contributes to L‐asparaginase resistance in solid tumors
    Jianhui Sun et al, 2019, EMBO J CrossRef
12. What makes a good new therapeutic l-asparaginase?
    Angela Beckett et al, 2019, World J Microbiol Biotechnol CrossRef
13. Cell mass-dependent expression of an anticancer protein drug by tumor-targeted Salmonella
    Kwangsoo Kim et al, 2018, Oncotarget CrossRef
14. Autophagy suppression potentiates the anti-glioblastoma effect of asparaginase in vitro and in vivo
    Qicheng Chen et al, 2017, Oncotarget CrossRef
15. Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy
    Nai-Yun Sun et al, 2020, Front. Oncol. CrossRef
16. Biomimetic Membrane-Structured Nanovesicles Carrying a Supramolecular Enzyme to Cure Lung Cancer
    Jing Gu et al, 2020, ACS Appl. Mater. Interfaces CrossRef
17. The role of asparagine synthetase on nutrient metabolism in pancreatic disease
    Cheng-Yu Tsai et al, 2020, Pancreatology CrossRef
18. A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias In Vivo
    Hien Anh Nguyen et al, 2018, Cancer Res CrossRef
19. TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity
    Jamilah Abusarah et al, 2021, Mol Cancer Ther CrossRef
20. Pharmacologic approaches to amino acid depletion for cancer therapy
    Carly S. Wilder et al, 2021, Molecular Carcinogenesis CrossRef
21. null
    Lucie Safrhansova et al, 2022 CrossRef
22. Glutamatergic system components as potential biomarkers and therapeutic targets in cancer in non-neural organs
    Ana Cristina García-Gaytán et al, 2022, Front. Endocrinol. CrossRef
23. The anticancer effect of PASylated calreticulin-targeting L-ASNase in solid tumor bearing mice with immunogenic cell death-inducing chemotherapy
    Ying Zhang et al, 2023, Biochemical Pharmacology CrossRef
24. Amino acid metabolism in health and disease
    Zhe-Nan Ling et al, 2023, Sig Transduct Target Ther CrossRef